Proxy Votes Now

Home › Funds › ProShares › Small-Cap Growth Profund

Small-Cap Growth Profund (SGPIX) proxy voting record 2025-2026

Fund family: ProShares · Filed by ProFunds (CIK 1039803) · SEC series S000003060

Share classes and tickers: SGPIX (C000008336), SGPSX (C000008337)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,874 with, 15 against, 0 abstentions (not counted as with management). Shareholder proposals: 11 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with ProShares as a whole

The same two figures as ProShares’s manager page (303,945 ballot items across 135 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsProSharesItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.9%2,81791.4%279,029
Backed environmental and social shareholder proposals at US companiesn/a110.6%4,043

Where this fund voted differently from most ProShares funds

Each ballot item this fund voted is set against the votes of the other ProShares funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most ProShares funds on all 2,792 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 97.6% of this fund’s 2,889 such votes could be given a sector; the other 70 (2.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance54710.2%
Consumer Discretionary54471.3%
Health Care40441.0%
Industrials37010.3%
Technology35610.3%
Real Estate24300.0%
Utilities10600.0%
Energy8400.0%
Consumer Staples6700.0%
Telecommunications5311.9%
Miscellaneous4200.0%
Basic Materials300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2,0425
Say-on-Pay3550
Audit-related3200
Compensation990
Corporate Governance588
Extraordinary Transactions230
Capital Structure120
Shareholder Rights and Defenses81
Human Rights or Human Capital/workforce11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
TG Therapeutics, Inc.June 11, 2026$82,40480
Armstrong World Industries, Inc.June 11, 2026$72,157120
Ligand Pharmaceuticals IncorporatedJune 5, 2026$56,420110
CSW Industrials, Inc.August 28, 2025$55,380100
Protagonist Therapeutics, Inc.June 17, 2026$54,55150
Brinker International, Inc.November 20, 2025$51,066120
Clear Secure, Inc.June 10, 2026$47,809130
Glaukos CorporationMay 28, 2026$45,54940

Notable votes against management

MeetingCompanyProposalFundMgmt
June 9, 2026Etsy, Inc.Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposalAgainstFor
March 9, 2026Sanmina CorporationTo consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposalAgainstFor
June 10, 2026MarketAxess Holdings Inc.If properly presented, a stockholder proposal regarding changes to existing stockholder special meeting right. Shareholder proposalForAgainst
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposalWithholdFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposalWithholdFor
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalForAgainst
May 5, 2026SkyWest, Inc.A shareholder proposal regarding collective bargaining policy. Shareholder proposalForAgainst
May 14, 2026Calix, Inc.To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposalForAgainst
December 15, 2025UniFirst CorporationTo elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposalForAgainst
May 20, 2026Lumen Technologies, Inc.Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposalForAgainst
June 3, 2026Resideo Technologies, Inc.Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Funds that vote the same way

These funds reported the same votes as Small-Cap Growth Profund in the latest season, so they share this page:

Search this fund’s votes by company

2,918 ballot items at 341 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small-Cap Growth Profund (SGPIX) voted at 341 shareholder meetings of 335 companies, on 2,918 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 15 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 16 shareholder proposals. It voted FOR the board's own proposals more often than ProShares's funds as a whole (91.9% against 91.4%). It voted the same way as most ProShares funds on every item where a comparison was possible. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of ProShares’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.